StemRIM (TSE:4599) Cash-to-Debt : No Debt ⁽¹⁾ (As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is StemRIM Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. StemRIM's cash to debt ratio for the quarter that ended in Jan. 2024 was No Debt ⁽¹⁾.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, StemRIM could pay off its debt using the cash in hand for the quarter that ended in Jan. 2024.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for StemRIM's Cash-to-Debt or its related term are showing as below:

TSE:4599' s Cash-to-Debt Range Over the Past 10 Years
Min: 197.86 Med: 1758.64 Max: 19242.49
Current: 17295.56

During the past 7 years, StemRIM's highest Cash to Debt Ratio was 19242.49. The lowest was 197.86. And the median was 1758.64.

TSE:4599's Cash-to-Debt is ranked better than
99.87% of 1535 companies
in the Biotechnology industry
Industry Median: 6.49 vs TSE:4599: 17295.56

StemRIM Cash-to-Debt Historical Data

The historical data trend for StemRIM's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

StemRIM Cash-to-Debt Chart

StemRIM Annual Data

Trend

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Cash-to-Debt

Get a 7-Day Free Trial

197.86

1,099.07

1,510.80

2,418.35

19,242.49

StemRIM Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Cash-to-Debt	Get a 7-Day Free Trial															3,982.11	5,981.49	19,242.49	No Debt	No Debt

Competitive Comparison of StemRIM's Cash-to-Debt

For the Biotechnology subindustry, StemRIM's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

StemRIM's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, StemRIM's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where StemRIM's Cash-to-Debt falls into.

StemRIM Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

StemRIM's Cash to Debt Ratio for the fiscal year that ended in Jul. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	10217.764	/	(0.531	+	0)
	=	19,242.49

StemRIM's Cash to Debt Ratio for the quarter that ended in Jan. 2024 is calculated as:

StemRIM had no debt ⁽¹⁾.

StemRIM (TSE:4599) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

StemRIM Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of StemRIM's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

StemRIM (TSE:4599) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemRIM Inc (TSE:4599) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

7-15 Ayato Bio Incubator 3rd floor, Ayato Asagi 7-chome, Prefecture Ibaraki City, Osaka, JPN, 567-0085

Website

https://www.stemrim.com

StemRIM Inc is a biotechnology company engaged in developing regeneration-guided medicines. The business activity of the group includes research, development, manufacture, and sales of pharmaceuticals and medical devices and products such as gene therapy that activate stem cells existing in the body and induce regeneration of damaged tissue.

StemRIM (TSE:4599) Headlines

No Headlines

StemRIM (TSE:4599) Cash-to-Debt : No Debt (1) (As of Jan. 2024)